Canada markets closed

Kane Biotech Inc. (KNBIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1010+0.0071 (+7.61%)
At close: 10:10AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
2,744
156.733
1,608
1,342
Cost of Revenue
1,433
44.704
1,039
814.715
Gross Profit
1,311
112.029
568.441
526.859
Operating Expenses
Research Development
837.889
1,036
1,377
1,326
Selling General and Administrative
3,777
2,534
4,075
3,425
Total Operating Expenses
4,614
3,570
5,452
4,751
Operating Income or Loss
-3,303
-3,458
-4,884
-4,224
Interest Expense
1,236
816.664
416.057
121.556
Total Other Income/Expenses Net
-27.018
237.168
327.773
461.653
Income Before Tax
-4,496
-4,022
-4,850
-3,846
Income from Continuing Operations
-4,496
-4,022
-4,850
-3,846
Net Income
-4,322
-3,890
-4,605
-3,717
Net Income available to common shareholders
-4,322
-3,890
-4,605
-3,717
Basic EPS
-0.04
-0.03
-0.04
-0.03
Diluted EPS
-0.04
-0.03
-0.04
-0.03
Basic Average Shares
112,600
120,702
112,600
108,614
Diluted Average Shares
112,600
120,702
112,600
108,614